You are required to be logged in to access the full website
Click here if you have forgotten your username or password
19 November 2026 - China-based biopharmaceutical company Innogen Pharmaceuticals (HKEX: 2591) said on Thursday it has signed an exclusive licensing and commercialisation agreement with Arcera Life Sciences for its internally developed GLP-1 therapy, ...
19 November 2026 - Professional services company Jacobs (NYSE:J) said on Thursday that it has been appointed by French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) as the engineering, procurement and construction management (EPCM)...
19 November 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday that it has entered into a strategic research collaboration with Isomorphic Labs, an AI-first drug design and de...
19 November 2026 - Swedish pharmaceutical company Dicot Pharma AB (Nasdaq First North:DICOT) announced on Thursday that it has received regulatory approval to initiate its phase 2b clinical study of LIB-01 in the European Union, with Sweden becoming ...
19 November 2026 - French biopharmaceutical company NFL Biosciences (Euronext Growth Paris:ALNFL) said on Thursday that it has enrolled the first participant in its Phase 2 TONIC clinical study evaluating NFL-102 for smoking and nicotine cessation, m...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe